243 related articles for article (PubMed ID: 26959706)
21. PCSK9 inhibition in LDL cholesterol reduction: genetics and therapeutic implications of very low plasma lipoprotein levels.
Marais AD; Kim JB; Wasserman SM; Lambert G
Pharmacol Ther; 2015 Jan; 145():58-66. PubMed ID: 25046268
[TBL] [Abstract][Full Text] [Related]
22. Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments.
Della-Morte D; Guadagni F; Palmirotta R; Testa G; Caso V; Paciaroni M; Abete P; Rengo F; Ferroni P; Sacco RL; Rundek T
Pharmacogenomics; 2012 Apr; 13(5):595-613. PubMed ID: 22462751
[TBL] [Abstract][Full Text] [Related]
23. A more accurate approach to molecular genetics analysis in vascular disease.
Villadóniga JI
Cardiovasc Hematol Disord Drug Targets; 2008 Sep; 8(3):212-27. PubMed ID: 18781934
[TBL] [Abstract][Full Text] [Related]
24. Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk.
Bergeron N; Phan BA; Ding Y; Fong A; Krauss RM
Circulation; 2015 Oct; 132(17):1648-66. PubMed ID: 26503748
[TBL] [Abstract][Full Text] [Related]
25. Prediction of first events of coronary heart disease and stroke with consideration of adiposity.
Wilson PW; Bozeman SR; Burton TM; Hoaglin DC; Ben-Joseph R; Pashos CL
Circulation; 2008 Jul; 118(2):124-30. PubMed ID: 18591432
[TBL] [Abstract][Full Text] [Related]
26. Health-related disparities: influence of environmental factors.
Olden K; White SL
Med Clin North Am; 2005 Jul; 89(4):721-38. PubMed ID: 15925646
[TBL] [Abstract][Full Text] [Related]
27. Cerebrovascular Diseases in Workers at Mayak PA: The Difference in Radiation Risk between Incidence and Mortality.
Simonetto C; Schöllnberger H; Azizova TV; Grigoryeva ES; Pikulina MV; Eidemüller M
PLoS One; 2015; 10(5):e0125904. PubMed ID: 25933038
[TBL] [Abstract][Full Text] [Related]
28. Cerebral small vessel disease: genetic risk assessment for prevention and treatment.
Lam A; Hamilton-Bruce MA; Jannes J; Koblar SA
Mol Diagn Ther; 2008; 12(3):145-56. PubMed ID: 18510378
[TBL] [Abstract][Full Text] [Related]
29. [Genetics of dyslipidemia--yesterday, today, and tomorrow].
Hubácek JA; Vrablík M
Vnitr Lek; 2007 Apr; 53(4):371-6. PubMed ID: 17578168
[TBL] [Abstract][Full Text] [Related]
30. Associations between white blood cell count and risk for cerebrovascular disease mortality: NHANES II Mortality Study, 1976-1992.
Brown DW; Ford ES; Giles WH; Croft JB; Balluz LS; Mokdad AH
Ann Epidemiol; 2004 Jul; 14(6):425-30. PubMed ID: 15246331
[TBL] [Abstract][Full Text] [Related]
31. [Enlightenment from genome-wide association study to genetics of psoriasis].
ZHANG XJ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):333-7. PubMed ID: 19693967
[TBL] [Abstract][Full Text] [Related]
32. Recent progress in understanding the genetic susceptibility to osteoporosis.
Zmuda JM; Cauley JA; Ferrell RE
Genet Epidemiol; 1999; 16(4):356-67. PubMed ID: 10207717
[TBL] [Abstract][Full Text] [Related]
33. Gene-environment interactions in the pathogenesis of type 2 diabetes and metabolism.
Grarup N; Andersen G
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):420-6. PubMed ID: 17563459
[TBL] [Abstract][Full Text] [Related]
34. Leveraging gene-environment interactions and endotypes for asthma gene discovery.
Bønnelykke K; Ober C
J Allergy Clin Immunol; 2016 Mar; 137(3):667-79. PubMed ID: 26947980
[TBL] [Abstract][Full Text] [Related]
35. The genetic architecture of intracerebral hemorrhage.
Rost NS; Greenberg SM; Rosand J
Stroke; 2008 Jul; 39(7):2166-73. PubMed ID: 18467649
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide association studies of late-onset cardiovascular disease.
Smith JG; Newton-Cheh C
J Mol Cell Cardiol; 2015 Jun; 83():131-41. PubMed ID: 25870159
[TBL] [Abstract][Full Text] [Related]
37. Advances in stroke 2009: update on the genetics of stroke and cerebrovascular disease 2009.
Hegele RA; Dichgans M
Stroke; 2010 Feb; 41(2):e63-6. PubMed ID: 20075351
[No Abstract] [Full Text] [Related]
38. Stroke genetics: discovery, biology, and clinical applications.
Dichgans M; Pulit SL; Rosand J
Lancet Neurol; 2019 Jun; 18(6):587-599. PubMed ID: 30975520
[TBL] [Abstract][Full Text] [Related]
39. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
40. Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation.
Tilg H; Moschen A
Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):391-6. PubMed ID: 20473151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
